CLS Therapeutics - Crunchbase Company Profile & Funding

Overview

CLS Therapeutics

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About CLS Therapeutics

CB Rank

776684

CLS Therapeutics is a biopharmaceutical firm that provides transformative gene therapy solutions for cancer patients.

Private

New City, New York, United States

11-50

clstherapeutics.com/

Biopharma

Biotechnology

Pharmaceutical

Therapeutics

Key People

Dmitry Genkin: Co-Founder and Director

Details

Operating Status

Active

Company Type

For Profit

Founders

Dmitry Genkin

Phone Number

1 646-617-3088

Contact Email

gtetz@clstherapeutics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CLS-014

An AAV-based gene therapy vector encoding hyperactive human DNase I designed to degrade cell-free DNA in the bloodstream to inhibit tumor growth and metastasis in pancreatic and other solid tumors.

Neutrophil Extracellular Traps (NETs) Blockade Therapy

A therapeutic approach combining DNase I treatment with PD-1 immune checkpoint inhibition to reduce tumor progression and improve immune response in metastatic colorectal cancer.